Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis.


Journal

Journal of cellular and molecular medicine
ISSN: 1582-4934
Titre abrégé: J Cell Mol Med
Pays: England
ID NLM: 101083777

Informations de publication

Date de publication:
10 2020
Historique:
received: 17 04 2020
accepted: 29 05 2020
pubmed: 6 9 2020
medline: 7 5 2021
entrez: 5 9 2020
Statut: ppublish

Résumé

Primary myelofibrosis (PMF) is a Ph-negative myeloproliferative neoplasm (MPN), characterized by advanced bone marrow fibrosis and extramedullary haematopoiesis. The bone marrow fibrosis results from excessive proliferation of fibroblasts that are influenced by several cytokines in the microenvironment, of which transforming growth factor-β (TGF-β) is the most important. Micromechanics related to the niche has not yet been elucidated. In this study, we hypothesized that mechanical stress modulates TGF-β signalling leading to further activation and subsequent proliferation and invasion of bone marrow fibroblasts, thus showing the important role of micromechanics in the development and progression of PMF, both in the bone marrow and in extramedullary sites. Using three PMF-derived fibroblast cell lines and transforming growth factor-β receptor (TGFBR) 1 and 2 knock-down PMF-derived fibroblasts, we showed that mechanical stress does stimulate the collagen synthesis by the fibroblasts in patients with myelofibrosis, through the TGFBR1, which however seems to be activated through alternative pathways, other than TGFBR2.

Identifiants

pubmed: 32889753
doi: 10.1111/jcmm.15526
pmc: PMC7576271
doi:

Substances chimiques

Transforming Growth Factor beta 0
Receptor, Transforming Growth Factor-beta Type I EC 2.7.11.30
Receptor, Transforming Growth Factor-beta Type II EC 2.7.11.30

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11100-11110

Informations de copyright

© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Références

Nature. 2011 Jun 15;474(7351):343-9
pubmed: 21677751
J Clin Invest. 2014 Jan;124(1):448-60
pubmed: 24355923
Ann Hematol. 2020 Apr;99(4):781-789
pubmed: 32076825
Biochem Biophys Res Commun. 2011 Jun 10;409(3):550-5
pubmed: 21605549
Nat Rev Cancer. 2020 Mar;20(3):174-186
pubmed: 31980749
Am J Hematol. 2017 Apr;92(4):E47-E48
pubmed: 28109034
Arch Biochem Biophys. 2018 Jan 1;637:31-39
pubmed: 29154781
Semin Hematol. 2007 Jul;44(3):166-82
pubmed: 17631181
J Gastrointestin Liver Dis. 2015 Dec;24(4):435-43
pubmed: 26697569
Nat Rev Drug Discov. 2019 Feb;18(2):99-115
pubmed: 30470818
Clin Lymphoma Myeloma Leuk. 2019 Sep;19(9):593-597
pubmed: 31262666
Leukemia. 2018 May;32(5):1057-1069
pubmed: 29515238
FEBS J. 2017 Jun;284(11):1644-1656
pubmed: 28342289
J Invest Dermatol. 1999 Jan;112(1):49-57
pubmed: 9886263
Am J Clin Pathol. 2010 Feb;133(2):314-20
pubmed: 20093242
Chem Biol Drug Des. 2016 Jun;87(6):927-35
pubmed: 26808072
Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):18813-8
pubmed: 16354837
J Exp Med. 2016 Aug 22;213(9):1723-40
pubmed: 27481130
Leukemia. 2017 May;31(5):1023-1038
pubmed: 28119526
J Cell Physiol. 2018 Jan;233(1):422-433
pubmed: 28294327
Nature. 2017 Apr 6;544(7648):105-109
pubmed: 28329764
J Mammary Gland Biol Neoplasia. 2016 Dec;21(3-4):139-148
pubmed: 27815674
Eur Cytokine Netw. 2008 Jun;19(2):69-80
pubmed: 18632420
Nat Commun. 2020 Mar 10;11(1):1290
pubmed: 32157087
Leukemia. 2017 Aug;31(8):1838-1839
pubmed: 28529309
Onco Targets Ther. 2017 Oct 19;10:5047-5051
pubmed: 29089774
Colloids Surf B Biointerfaces. 2018 Mar 1;163:155-166
pubmed: 29291501
Oncology (Williston Park). 2017 Jul 15;31(7):521-9
pubmed: 28712096
J Gastrointestin Liver Dis. 2017 Mar;26(1):45-50
pubmed: 28338113
Nat Rev Gastroenterol Hepatol. 2019 May;16(5):282-295
pubmed: 30778141
J Cell Sci. 2017 Jan 1;130(1):152-163
pubmed: 27199371
Haematologica. 2008 Oct;93(10):1593-5
pubmed: 18641018
Genome Res. 2018 Apr;28(4):432-447
pubmed: 29567676
Blood. 2013 Jun 6;121(23):4778-81
pubmed: 23591792
Exp Hematol. 2016 Dec;44(12):1138-1155.e4
pubmed: 27592389
Blood. 1978 Feb;51(2):189-94
pubmed: 620081
Dev Biol. 2015 Jul 15;403(2):150-61
pubmed: 25967125
Nature. 1994 Aug 4;370(6488):341-7
pubmed: 8047140
Acta Histochem. 2019 Apr;121(3):344-353
pubmed: 30808518
Leuk Lymphoma. 2019 Apr;60(4):876-885
pubmed: 30277128
Int J Nanomedicine. 2016 Feb 15;11:641-60
pubmed: 26929621
Histol Histopathol. 2019 Jun;34(6):663-670
pubmed: 30467824
Sci Rep. 2016 Jul 15;6:28752
pubmed: 27418435
Rom J Intern Med. 2016 Apr-Jun;54(2):98-104
pubmed: 27352438
J Biol Chem. 1983 Jun 10;258(11):7155-60
pubmed: 6602130
Proc Natl Acad Sci U S A. 1988 Aug;85(15):5625-8
pubmed: 2969593
Stem Cell Investig. 2016 Feb 26;3:5
pubmed: 27358897
Nanoscale Res Lett. 2015 Dec;10(1):466
pubmed: 26625890
J BUON. 2016 Jan-Feb;21(1):199-207
pubmed: 27061549
Crit Rev Clin Lab Sci. 2018 Nov;55(7):501-515
pubmed: 30238808
Am J Hematol. 2018 Dec;93(12):1551-1560
pubmed: 30039550
Stem Cells Dev. 2012 May 1;21(7):1176-86
pubmed: 21967638
Echo Res Pract. 2018 Sep;5(3):G11-G24
pubmed: 30012832
Haematologica. 2016 Jun;101(6):660-71
pubmed: 27252511
Eur J Intern Med. 2019 Oct;68:71-75
pubmed: 31421946
J Clin Invest. 2017 Feb 1;127(2):670-680
pubmed: 28112683
Nat Commun. 2017 Jan 27;8:14174
pubmed: 28128203
Blood. 2006 Jun 15;107(12):4589-96
pubmed: 16484590
Ann Hematol. 1999 Oct;78(10):437-44
pubmed: 10550553
J Cell Mol Med. 2020 Oct;24(19):11100-11110
pubmed: 32889753
Blood. 2007 Aug 1;110(3):986-93
pubmed: 17473062
Am J Hematol. 2018 Jan;93(1):100-106
pubmed: 29047144

Auteurs

Patric Teodorescu (P)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj Napoca, Romania.

Sergiu Pasca (S)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.

Ancuta Jurj (A)

Research Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.

Grigore Gafencu (G)

Research Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
Molecular Haematology Unit - Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.

Jon-Petur Joelsson (JP)

Stem Cell Research Unit, Biomedical Center, School of Health Sciences, University of Iceland, Reykjavík, Iceland.
Department of Laboratory Hematology, Landspitali University Hospital, Reykjavík, Iceland.

Sonia Selicean (S)

Research Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
Graduate School for Cellular and Biomedical Sciences, Universität Bern, Bern, Switzerland.

Cristian Moldovan (C)

Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.

Raluca Munteanu (R)

Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.

Anca Onaciu (A)

Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.

Adrian-Bogdan Tigu (AB)

Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.

Mihail Buse (M)

Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.

Alina-Andreea Zimta (AA)

Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.

Rares Stiufiuc (R)

Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.

Bobe Petrushev (B)

Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.

Minodora Desmirean (M)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
Department of Pathology, Constantin Papilian Military Hospital, Cluj Napoca, Romania.

Delia Dima (D)

Department of Hematology, Ion Chiricuta Clinical Research Center, Cluj Napoca, Romania.

Cristina Vlad (C)

Department of Cardiology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
Department of Cardiology, Rehabilitation Hospital, Cluj Napoca, Romania.

Jon Thor Bergthorsson (JT)

Stem Cell Research Unit, Biomedical Center, School of Health Sciences, University of Iceland, Reykjavík, Iceland.
Department of Laboratory Hematology, Landspitali, University Hospital, Reykjavík, Iceland.

Cristian Berce (C)

Animal Facility, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.

Stefan Ciurea (S)

Department of Cellular Therapies and Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Gabriel Ghiaur (G)

Department of Leukemia, Sidney Kimmel Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Ciprian Tomuleasa (C)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj Napoca, Romania.
Research Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH